Scott Houston is a Clinical Operations Leader with over 25 years of experience in the biotechnology and pharmaceutical sectors, providing strategic leadership and hands-on trial management to both large pharma and emerging biotech companies. As a fractional senior clinical operations consultant, he helps biotechs transition seamlessly from preclinical R&D to clinical trials with a resource-efficient, solutions-focused approach—delivering high-impact leadership without the overhead of a full-time internal team.Scott specializes in tailoring clinical trial strategies to the resource-constrained, innovative environments of small biotech firms, leading teams to scale operations efficiently and meet critical timelines. Known for offering calm, clear direction in high-pressure, fast-paced situations, he delivers actionable solutions that keep projects on track, ensuring timely and cost-effective outcomes.With extensive hands-on experience managing Phases I-III clinical trials across diverse therapeutic areas with innovative treatments, Scott excels in trial design, execution, and CRO management. He has extensive in-country experience managing clinical trials (healthy volunteer, treatment, and diagnostic) across 22+ countries, including key markets such as Australia, Canada, China, the EU, Japan, Russia, South Korea, Taiwan, the UK, Ukraine, and the USA. He ensures compliance with regulatory requirements (IND, BLA, NDA) and expertly navigates complex data delivery to facilitate successful approvals. Scott has been a key contributor to enabling regulatory approvals for Trisenox®, Gleevec®, Eloxatin®, Omidria®, and for the Akalux® IV Infusion / BioBlade® Laser System.As President of BayShore BioConsulting LLC, Scott provides tailored, cost-effective clinical trial solutions. His "Department of One" approach combines executive decision-making with hands-on clinical trial management, optimizing trial planning, aligning financial goals with costs, and ensuring smooth execution. This approach mitigates risks, addresses funding challenges, and helps biotech companies achieve milestones on time and within budget.